콘텐츠로 건너뛰기
Edisbiothec Logo
  • COMPANY
    • About Us
    • Leadership
    • History
    • Partnership
    • Contact Us
  • R&D
    • Basic concept /Core technology
    • Tumor microenvironment
    • Antibody-based cancer therapeutics
    • Biomarker-Based Precision Medicine
    • Molecular imaging
  • PIPELINE
    • Overview
    • ED1
    • ED2
  • PR
    • Notice
    • Press Release
    • Resource
  • ENG
    • KOR
  • COMPANY
    • About Us
    • Leadership
    • History
    • Partnership
    • Contact Us
  • R&D
    • Basic concept /Core technology
    • Tumor microenvironment
    • Antibody-based cancer therapeutics
    • Biomarker-Based Precision Medicine
    • Molecular imaging
  • PIPELINE
    • Overview
    • ED1
    • ED2
  • PR
    • Notice
    • Press Release
    • Resource

Notice & PR

  • Notice
  • Press Release
  • Resource
  • 16

    Myung Seung-Jae, President of the Korean Association for the Study of Intestinal Diseases (KASID), Awarded Commendation by the

    2022.10.07

  • 15

    20 Years Since Its Founding, Leaping Forward as a Center for Intestinal Research in Asia - Myung Seung-Jae, President of the Ko

    2022.09.27

  • 14

    With 100,000 patients suffering from Inflammatory Bowel Disease on the horizon, system improvements are needed for the 'Era of

    2022.05.03

  • 13

    Myung Seung-Jae, CEO of EdisBiotech, Challenges to develop new drug to prevent colorectal cancer metastasis

    2022.02.03

  • 12

    Ministry of Education 'Selected for the University-Focused Research Institute Support Project’, Professor Myung Seung-Jae, Head

    2021.06.10

  • 11

    Interview Commemorating World Inflammatory Bowel Disease Day.

    2021.05.21

  • 10

    Inflammatory bowel disease targeting younger generation: Early intervention needed to reduce risk of complications.

    2021.05.10

  • 9

    Asan Medical Center, Discovers intracellular nuclear receptor that suppresses stomach cancer growth.

    2018.06.12

  • 8

    Diagnosing cancer within 5 minutes using fluorescent drugs during a colonoscopy.

    2018.01.29

  • 7

    University of Ulsan is recruiting prospective entrepreneurs for its leading university entrepreneurship program.

    2017.07.04

  • 1
  • 2
  • »
  • Last

R&D

Core technologies and R&D background

PIPELINE

Biomarker-driven anti-cancer therapy development

To top

EdisBiotech

Address
Olympic-ro 43-gil, Songpa-gu, Seoul, Korea (11th floor, AMC Convergence Center)
Tel
02-3010-8589
EdisBiotech

COPYRIGHT 2024. EdisBiotech ALL RIGHTS RESERVED.

Contact Us
닫기